SCHEMBL983994

SCHEMBL983994

CC(C)c1ccccc1-c1ccccc1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 3/20 0.67
▸ GABRB2 P47870 2/20 0.67
▸ CA2 P00918 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ TSHR P16473 2/20 0.50
▸ CA1 P00915 2/20 0.50
▸ GABRG2 P18507 2/20 0.50
▸ GABRB3 P28472 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ BLM P54132 2/20 0.50
▸ HIF1A Q16665 2/20 0.50
▸ SLC6A2 P23975 2/20 0.50
▸ HTR2B P41595 2/20 0.50
▸ FAAH O00519 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ GABRB1 P18505 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ HTR2C P28335 1/20 0.50
▸ GABRA5 P31644 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL9644435 0.85 GABRA1 (0.56) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL9742878 0.85 GABRA1 (0.59) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL29414063 0.85 GABRA1 (0.55) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL167078 0.85 GABRA1 (0.55) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL12096898 0.84 GABRA1 (0.52) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL8347129 0.84 GABRA1 (0.52) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL28762441 0.84 GABRA1 (0.57) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL1841574 0.84 GABRA1 (0.57) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL10438529 0.84 GABRA1 (0.57) GABRA1GABRB2CA2HPGDLMNA
SCHEMBL9174922 0.83 GABRA1 (0.52) GABRA1GABRB2CA2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024105479-A1 CHEMICALLY RESISTANT POLYCARBONATE COMPOSITIONS AND ARTICLES MADE THEREFROM SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2024-05-23 — — WO disclosed
US-20240130937-A1 ORAL CARE COMPOSITION LACER, S.A. (ES) 2024-04-25 — — US disclosed
US-20240099949-A1 ORAL CARE COMPOSITION LACER, S.A. (ES) 2024-03-28 — — US disclosed
CN-117222682-A Cured resin composition and cured product thereof 日本化药株式会社 2023-12-12 — — CN disclosed
EP-4044996-B1 ORAL CARE COMPOSITION LACER SA (ES) 2023-12-06 — — EP disclosed
EP-4044995-B1 ORAL CARE COMPOSITION LACER SA (ES) 2023-11-22 — — EP disclosed
US-20230365488-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-11-16 — — US disclosed
CN-113461504-B Method for preparing macrocyclic ketone from epoxide 中国天辰工程有限公司 2023-04-21 — — CN disclosed
CN-111224165-B Preparation method of flame-retardant lithium salt with high organic compatibility and composite flame-retardant electrolyte thereof 山东理工大学 2023-02-10 — — CN disclosed
CN-111211350-B Preparation method of melamine-ring-containing flame-retardant electrolyte easily soluble in organic solvent 山东理工大学 2023-02-10 — — CN disclosed
EP-1928659-A1 MULTILAYER FILMS COMPRISING TIE LAYER COMPOSITIONS, ARTICLES PREPARED THEREFROM, AND METHOD OF MAKING General Electric Company (US) 2008-06-11 — — EP disclosed
WO-2007040973-A1 MULTILAYER FILMS COMPRISING TIE LAYER COMPOSITIONS, ARTICLES PREPARED THEREFROM, AND METHOD OF MAKING GENERAL ELECTRIC COMPANY (US) 2007-04-12 — — WO disclosed
CN-1333467-A Optical fibre core and method for making optical fibre band SHIN ESTU CHEMICAL CO LTD (JP) 2002-01-30 — — CN disclosed
EP-0407801-B1 Process for the preparation of phosphoraryl esters with alphamethylbenzylphenoxy groups BAYER AG (DE) 1994-09-07 — — EP disclosed
US-5250606-A Polymer blend compositions containing a styrenic copolymer, an acetal polymer and a thermoplastic polyester or polycarbonate resin ingredient THE DOW CHEMICAL COMPANY (US) 1993-10-05 — — US disclosed
EP-0466906-A1 STYRENIC COPOLYMER BLEND COMPOSITIONS HAVING IMPROVED COLOR STABILITY THE DOW CHEMICAL COMPANY (US) 1992-01-22 — — EP disclosed
WO-1991011487-A1 STYRENIC COPOLYMER BLEND COMPOSITIONS HAVING IMPROVED COLOR STABILITY THE DOW CHEMICAL COMPANY (US) 1991-08-08 — — WO disclosed
EP-0440442-A1 Polymer blend compositions containing a styrenic copolymer, an acetal polymer and a thermoplastic polyester or polycarbonate resin ingredient THE DOW CHEMICAL COMPANY (US) 1991-08-07 — — EP disclosed
EP-0408928-A1 Method for the production of alpha-methylbenzyl-substituted phenols BAYER AG (DE) 1991-01-23 — — EP disclosed
EP-0407801-A1 Process for the preparation of phosphoraryl esters with alphamethylbenzylphenoxy groups BAYER AG (DE) 1991-01-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240130937-A1 ORAL CARE COMPOSITION IKZF2, ZNF277, IKZF3 GABRA1 2207/4885GABRB2 2488/4885CA2 486/4885
US-20240099949-A1 ORAL CARE COMPOSITION MGAT3, IL17A, HSD3B1 GABRA1 3430/4885GABRB2 3680/4885CA2 608/4885
US-20230365488-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FABP5, FABP1, FABP4 GABRA1 698/4885GABRB2 686/4885CA2 2632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback